Clinical Trial Update: Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion status of a Phase 1/2 clinical trial evaluating TRV120027 in patients with heart failure. The sponsor is Trevena Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• TRV120027

Snippet

Sponsor: Trevena Inc. | Conditions: Heart Failure | Phase 1, Phase 2 | Status: COMPLETED